Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions.
Anuradha Lala, Maya H Barghash, Gennaro Giustino...
https://pubmed.ncbi.nlm.nih.gov/33336881/Actively Recruiting
Led by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Updated on 2026-03-19
1014
Participants Needed
25
Research Sites
8 weeks
Total Duration
Researchers are evaluating whether a treatment strategy guided by the Remote Dielectric Sensing ReDS device is better than the current usual care for adults hospitalized with heart failure. The study also aims to assess the safety and cost-effectiveness of this ReDS-guided approach. The goal is to see if this strategy can reduce the risk of cardiovascular events within the first month after hospital discharge and to understand its safety profile. Participants will be randomly assigned to one of two groups. In the ReDS-guided group, clinicians will use daily ReDS measurements to adjust treatment following a specific diuretic protocol until stability and lung fluid reduction criteria are met. The control group will receive usual care without access to ReDS data, with treatment decisions based on clinical judgment and local practice. Patients will remain hospitalized until clinical stability is achieved according to defined criteria, including weight loss, biomarker reduction, and edema score. After discharge, all participants will have two follow-up visits at 2 weeks and 30 days. During the study, participants will undergo daily lung fluid assessments using the ReDS device while hospitalized. Researchers will monitor the number of cardiovascular events and safety issues within one month after discharge. They will also track hospital stay length to evaluate cost-effectiveness. Follow-up visits at 2 weeks and 30 days will include assessments to measure these outcomes. The total participation period covers hospitalization plus one month after discharge, with close monitoring throughout.
CONDITIONS
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
J
Jesús Álvarez-García, MD, PhD
C
Cristina Rey Iborra, BSN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead Sponsor
Hospital Universitario Ramon y Cajal
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Duration of hospitalization until clinical stability criteria are met
Participants receive either the ReDS-guided treatment strategy or usual clinical care during hospitalization. Daily ReDS measurements are taken in the experimental group to guide fluid removal. Treatment adjustments and discharge decisions are made based on clinical stability and ReDS criteria or clinical judgment in the usual care group.
Daily assessments during hospitalization
Duration - 30 days after hospital discharge
Participants attend two follow-up visits after discharge at 2 weeks and 30 days to assess safety and heart-related events.
2 visits post-discharge
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anuradha Lala, Maya H Barghash, Gennaro Giustino...
https://pubmed.ncbi.nlm.nih.gov/33336881/Jesus Alvarez-Garcia, Anuradha Lala, Mercedes Rivas-Lasarte...
https://pubmed.ncbi.nlm.nih.gov/38430084/Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Lead Sponsor
Hospital Universitario Ramon y Cajal
Collaborating Sponsor